ARDX ARDELYX, INC.
Nasdaq · SEC CIK 1437402 · EDGAR
- Bought, last 12 months
- $1.95M 1 purchases by 1 insiders
- Sold, last 12 months
- $4.30M 38 sales by 9 insiders
- Filings on record
- 324 since 2021-08-05, latest 2026-08-25 19:19
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| RAAB MICHAEL | Pres, CEO, Dir | — | $2.57M |
| MOTT DAVID M | Dir | $1.95M | — |
| Williams Laura A | See Remarks | — | $1.01M |
| Foster Eric Duane | Chief Commercial Off | — | $176.4K |
| Kelliher Mike | See Remarks | — | $162.3K |
| Reilly Joseph James | See Remarks | — | $129.3K |
| Bishop John E | See Remarks | — | $109.2K |
| Brady James Parker | CHRO | — | $84.8K |
| GRAMMER ELIZABETH A | See Remarks | — | $33.2K |
| Hohenleitner Susan | CFO | — | $27.0K |
Transactions 368
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-18 | 2024-01-16 | ARDX | GRAMMER ELIZABETH A | See Remarks | A - Grant | $0.00 | +127.8K | 403.4K | +46% | $0 |
| D | 2024-01-18 | 2024-01-16 | ARDX | Renz Justin A | CFO | A - Grant | $0.00 | +127.8K | 310.2K | +70% | $0 |
| D | 2024-01-18 | 2024-01-16 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | A - Grant | $0.00 | +475.0K | 1.34M | +55% | $0 |
| D | 2024-01-18 | 2024-01-16 | ARDX | Felsch Robert Ora | See Remarks | A - Grant | $0.00 | +70.1K | 187.2K | +60% | $0 |
| D | 2024-01-18 | 2024-01-16 | ARDX | Rodriguez Susan | Chief Commercial Off | A - Grant | $0.00 | +112.8K | 459.7K | +32% | $0 |
| D | 2024-01-18 | 2024-01-16 | ARDX | Williams Laura A | Chief Medical Off | A - Grant | $0.00 | +118.8K | 384.9K | +45% | $0 |
| D | 2024-01-18 | 2024-01-16 | ARDX | Rosenbaum David P. | Chief Development Off | A - Grant | $0.00 | +112.8K | 399.3K | +39% | $0 |
| DI | 2024-01-18 | 2024-01-16 | ARDX | Rosenbaum David P. | Chief Development Off | A - Grant | $0.00 | +70.1K | 183.4K | +62% | $0 |
| D | 2024-01-18 | 2024-01-16 | ARDX | Blanks Robert | See Remarks | A - Grant | $0.00 | +112.8K | 373.2K | +43% | $0 |
| 2024-01-10 | 2024-01-08 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $6.64 | -30.0K | 286.6K | -9% | -$199.2K | |
| D | 2023-12-28 | 2023-12-26 | ARDX | Renz Justin A | CFO | M - OptEx | $0.99 | +75.0K | 407.4K | +23% | +$74.2K |
| D | 2023-12-28 | 2023-12-26 | ARDX | Renz Justin A | CFO | S - Sale+OE | $6.36 | -225.0K | 182.4K | -55% | -$1.43M |
| 2023-12-20 | 2023-12-18 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $6.07 | -5,675 | 316.6K | -2% | -$34.4K | |
| 2023-12-15 | 2023-12-14 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $5.55 | -7,000 | 322.3K | -2% | -$38.9K | |
| 2023-12-13 | 2023-12-11 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $5.08 | -50.0K | 275.7K | -15% | -$254.0K | |
| 2023-12-08 | 2023-12-08 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $5.27 | -20.0K | 329.3K | -6% | -$105.4K | |
| 2023-12-06 | 2023-12-05 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $5.00 | -10.3K | 349.3K | -3% | -$51.4K | |
| 2023-12-01 | 2023-11-30 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $4.50 | -3,000 | 359.5K | -0.8% | -$13.5K | |
| 2023-11-22 | 2023-11-20 | ARDX | Renz Justin A | CFO | S - Sale | $4.36 | -2,873 | 332.4K | -0.9% | -$12.5K | |
| 2023-11-22 | 2023-11-20 | ARDX | Rodriguez Susan | Chief Commercial Off | S - Sale | $4.36 | -4,714 | 347.0K | -1% | -$20.6K | |
| 2023-11-22 | 2023-11-20 | ARDX | Blanks Robert | See Remarks | S - Sale | $4.36 | -2,835 | 260.5K | -1% | -$12.4K | |
| 2023-11-22 | 2023-11-20 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $4.36 | -2,581 | 266.2K | -1.0% | -$11.3K | |
| 2023-11-22 | 2023-11-20 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $4.36 | -2,835 | 362.5K | -0.8% | -$12.4K | |
| I | 2023-11-22 | 2023-11-20 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $4.36 | -932 | 113.3K | -0.8% | -$4,064 |
| 2023-11-22 | 2023-11-20 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $4.36 | -2,384 | 325.7K | -0.7% | -$10.4K | |
| 2023-11-22 | 2023-11-20 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $4.36 | -1,044 | 117.1K | -0.9% | -$4,552 | |
| 2023-11-22 | 2023-11-20 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $4.36 | -11.4K | 867.9K | -1% | -$49.6K | |
| 2023-11-17 | 2023-11-15 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $4.00 | -25.0K | 266.8K | -9% | -$100.0K | |
| 2023-10-12 | 2023-10-10 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $4.00 | -1,644 | 365.4K | -0.4% | -$6,576 | |
| T | 2023-09-12 | 2023-09-08 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $4.55 | -2,897 | 367.0K | -0.8% | -$13.2K |
| 2023-08-23 | 2023-08-21 | ARDX | Rodriguez Susan | Chief Commercial Off | S - Sale | $3.55 | -4,733 | 348.7K | -1% | -$16.8K | |
| 2023-08-23 | 2023-08-21 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $3.55 | -2,591 | 291.8K | -0.9% | -$9,198 | |
| 2023-08-23 | 2023-08-21 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $3.55 | -1,048 | 115.1K | -0.9% | -$3,720 | |
| 2023-08-23 | 2023-08-21 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $3.55 | -11.4K | 876.2K | -1% | -$40.5K | |
| 2023-08-23 | 2023-08-21 | ARDX | Blanks Robert | See Remarks | S - Sale | $3.55 | -2,846 | 263.3K | -1% | -$10.1K | |
| 2023-08-23 | 2023-08-21 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $3.55 | -2,846 | 369.9K | -0.8% | -$10.1K | |
| I | 2023-08-23 | 2023-08-21 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $3.55 | -937 | 111.2K | -0.8% | -$3,326 |
| 2023-08-23 | 2023-08-21 | ARDX | Renz Justin A | CFO | S - Sale | $3.55 | -2,884 | 333.8K | -0.9% | -$10.2K | |
| 2023-08-23 | 2023-08-21 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $3.55 | -2,392 | 328.1K | -0.7% | -$8,492 | |
| 2023-06-29 | 2023-06-27 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $3.35 | -25.0K | 294.4K | -8% | -$83.8K | |
| D | 2023-06-27 | 2023-06-23 | ARDX | Blanks Robert | See Remarks | S - Sale+OE | $3.63 | -33.3K | 266.1K | -11% | -$121.0K |
| D | 2023-06-27 | 2023-06-23 | ARDX | Blanks Robert | See Remarks | M - OptEx | $3.42 | +33.3K | 299.5K | +13% | +$114.0K |
| D | 2023-06-16 | 2023-06-15 | ARDX | Cadoret-Manier Onaiza | Dir | A - Grant | $0.00 | +12.8K | 110.2K | +13% | $0 |
| D | 2023-06-16 | 2023-06-15 | ARDX | Rodgers Richard J | Dir | A - Grant | $0.00 | +18.5K | 238.3K | +8% | $0 |
| D | 2023-06-16 | 2023-06-15 | ARDX | MOTT DAVID M | Dir | A - Grant | $0.00 | +25.5K | 1.19M | +2% | $0 |
| D | 2023-06-16 | 2023-06-15 | ARDX | Bertrand William C JR | Dir | A - Grant | $0.00 | +16.6K | 218.7K | +8% | $0 |
| D | 2023-06-16 | 2023-06-15 | ARDX | Lundberg Jan M | Dir | A - Grant | $0.00 | +12.8K | 146.8K | +10% | $0 |
| 2023-05-25 | 2023-05-23 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $3.65 | -11.4K | 887.7K | -1% | -$41.5K | |
| I | 2023-05-25 | 2023-05-23 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $3.65 | -934 | 112.2K | -0.8% | -$3,409 |
| 2023-05-25 | 2023-05-23 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $3.65 | -2,835 | 372.8K | -0.8% | -$10.3K | |
| 2023-05-25 | 2023-05-23 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $3.65 | -1,046 | 116.2K | -0.9% | -$3,818 | |
| 2023-05-25 | 2023-05-23 | ARDX | Rodriguez Susan | Chief Commercial Off | S - Sale | $3.65 | -4,711 | 353.4K | -1% | -$17.2K | |
| 2023-05-25 | 2023-05-23 | ARDX | Blanks Robert | See Remarks | S - Sale | $3.65 | -2,835 | 266.1K | -1% | -$10.3K | |
| 2023-05-25 | 2023-05-23 | ARDX | Renz Justin A | CFO | S - Sale | $3.65 | -2,873 | 336.7K | -0.8% | -$10.5K | |
| 2023-05-25 | 2023-05-23 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $3.65 | -2,583 | 319.4K | -0.8% | -$9,428 | |
| 2023-05-25 | 2023-05-23 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $3.65 | -2,384 | 330.5K | -0.7% | -$8,702 | |
| I | 2023-03-31 | 2023-03-29 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $4.63 | -3,000 | 113.1K | -3% | -$13.9K |
| 2023-03-02 | 2023-02-21 | ARDX | Rodriguez Susan | Chief Commercial Off | S - Sale | $3.00 | -5,586 | 355.1K | -2% | -$16.8K | |
| 2023-02-24 | 2023-02-21 | ARDX | Renz Justin A | CFO | S - Sale | $3.00 | -3,439 | 336.6K | -1% | -$10.3K | |
| 2023-02-24 | 2023-02-21 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $3.00 | -13.4K | 896.0K | -1% | -$40.3K | |
| 2023-02-24 | 2023-02-21 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $3.00 | -3,187 | 319.0K | -1.0% | -$9,561 | |
| I | 2023-02-24 | 2023-02-21 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $3.00 | -1,114 | 113.1K | -1.0% | -$3,342 |
| 2023-02-24 | 2023-02-21 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $3.00 | -3,394 | 375.6K | -0.9% | -$10.2K | |
| 2023-02-24 | 2023-02-21 | ARDX | Felsch Robert Ora | See Remarks | S - Sale | $3.00 | -3,214 | 114.2K | -3% | -$9,642 | |
| 2023-02-24 | 2023-02-21 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $3.00 | -2,914 | 330.0K | -0.9% | -$8,742 | |
| 2023-02-24 | 2023-02-21 | ARDX | Blanks Robert | See Remarks | S - Sale | $3.00 | -3,394 | 269.0K | -1% | -$10.2K | |
| D | 2023-01-06 | 2023-01-05 | ARDX | Williams Laura A | Chief Medical Off | A - Grant | $0.00 | +78.0K | 322.2K | +32% | $0 |
| D | 2023-01-06 | 2023-01-05 | ARDX | Renz Justin A | CFO | A - Grant | $0.00 | +78.0K | 340.0K | +30% | $0 |
| D | 2023-01-06 | 2023-01-05 | ARDX | Felsch Robert Ora | See Remarks | A - Grant | $0.00 | +26.0K | 117.4K | +28% | $0 |
| D | 2023-01-06 | 2023-01-05 | ARDX | Rosenbaum David P. | Chief Development Off | A - Grant | $0.00 | +78.0K | 379.0K | +26% | $0 |
| DI | 2023-01-06 | 2023-01-05 | ARDX | Rosenbaum David P. | Chief Development Off | A - Grant | $0.00 | +25.3K | 114.2K | +28% | $0 |
| D | 2023-01-06 | 2023-01-05 | ARDX | GRAMMER ELIZABETH A | See Remarks | A - Grant | $0.00 | +78.0K | 332.9K | +31% | $0 |
| D | 2023-01-06 | 2023-01-05 | ARDX | Blanks Robert | See Remarks | A - Grant | $0.00 | +78.0K | 272.4K | +40% | $0 |
| D | 2023-01-06 | 2023-01-05 | ARDX | Rodriguez Susan | Chief Commercial Off | A - Grant | $0.00 | +78.0K | 360.7K | +28% | $0 |
| D | 2023-01-06 | 2023-01-05 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | A - Grant | $0.00 | +250.0K | 909.5K | +38% | $0 |
| M | 2022-11-23 | 2022-11-22 | ARDX | GRAMMER ELIZABETH A | See Remarks | S - Sale | $1.95 | -1,242 | 256.1K | -0.5% | -$2,422 |
| M | 2022-11-23 | 2022-11-22 | ARDX | Rodriguez Susan | Chief Commercial Off | S - Sale | $1.95 | -3,456 | 286.0K | -1% | -$6,738 |
| MI | 2022-11-23 | 2022-11-22 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $1.95 | -484 | 88.9K | -0.5% | -$943.69 |
| M | 2022-11-23 | 2022-11-22 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $1.95 | -1,464 | 302.4K | -0.5% | -$2,855 |
| M | 2022-11-23 | 2022-11-22 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $1.95 | -6,219 | 659.5K | -0.9% | -$12.1K |
| M | 2022-11-23 | 2022-11-22 | ARDX | Renz Justin A | CFO | S - Sale | $1.95 | -1,504 | 262.0K | -0.6% | -$2,932 |
| M | 2022-11-23 | 2022-11-22 | ARDX | Blanks Robert | See Remarks | S - Sale | $1.95 | -1,464 | 194.4K | -0.7% | -$2,854 |
| M | 2022-11-23 | 2022-11-22 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $1.95 | -1,241 | 245.4K | -0.5% | -$2,420 |
| 2022-11-17 | 2022-11-17 | ARDX | MOTT DAVID M | Dir | P - Purchase | $1.76 | +567.0K | 1.17M | +95% | +$997.9K | |
| 2022-10-07 | 2022-10-05 | ARDX | Blanks Robert | See Remarks | S - Sale | $1.50 | -100.0K | 195.8K | -34% | -$150.0K | |
| 2022-09-01 | 2022-08-31 | ARDX | Felsch Robert Ora | See Remarks | P - Purchase | $0.62 | +3,000 | 91.4K | +3% | +$1,860 | |
| 2022-09-01 | 2022-08-31 | ARDX | GRAMMER ELIZABETH A | See Remarks | P - Purchase | $0.62 | +3,000 | 256.1K | +1% | +$1,860 | |
| I | 2022-09-01 | 2022-09-01 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $0.92 | -3,000 | 89.4K | -3% | -$2,760 |
| I | 2022-09-01 | 2022-08-31 | ARDX | Rosenbaum David P. | Chief Development Off | P - Purchase | $0.62 | +3,000 | 92.4K | +3% | +$1,860 |
| 2022-09-01 | 2022-08-31 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | P - Purchase | $0.62 | +3,000 | 665.7K | +0.5% | +$1,860 | |
| 2022-09-01 | 2022-08-31 | ARDX | Renz Justin A | CFO | P - Purchase | $0.62 | +3,000 | 263.5K | +1% | +$1,860 | |
| 2022-09-01 | 2022-08-31 | ARDX | Williams Laura A | Chief Medical Off | P - Purchase | $0.62 | +3,000 | 245.4K | +1% | +$1,860 | |
| 2022-08-29 | 2022-08-26 | ARDX | Blanks Robert | See Remarks | S - Sale | $1.04 | -21.8K | 295.8K | -7% | -$22.7K | |
| M | 2022-08-24 | 2022-08-22 | ARDX | Williams Laura A | Chief Medical Off | S - Sale | $0.98 | -1,276 | 242.5K | -0.5% | -$1,250 |
| M | 2022-08-24 | 2022-08-22 | ARDX | RAAB MICHAEL | Pres, CEO, Dir | S - Sale | $0.98 | -6,146 | 662.8K | -0.9% | -$6,023 |
| M | 2022-08-24 | 2022-08-22 | ARDX | Rodriguez Susan | Chief Commercial Off | S - Sale | $0.98 | -3,420 | 286.2K | -1% | -$3,352 |
| M | 2022-08-24 | 2022-08-22 | ARDX | Blanks Robert | See Remarks | S - Sale | $0.98 | -1,458 | 317.7K | -0.5% | -$1,429 |
| M | 2022-08-24 | 2022-08-22 | ARDX | Renz Justin A | CFO | S - Sale | $0.98 | -1,498 | 260.5K | -0.6% | -$1,468 |
| MI | 2022-08-24 | 2022-08-22 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $0.98 | -497 | 89.4K | -0.6% | -$487.06 |
| M | 2022-08-24 | 2022-08-22 | ARDX | Rosenbaum David P. | Chief Development Off | S - Sale | $0.98 | -1,458 | 302.5K | -0.5% | -$1,429 |
Purchase Sale Sale after option exercise All abbreviations